Group 1 - Broadcom Inc. (NASDAQ:AVGO) is included in the Ken Fisher Stock Portfolio as one of the 12 best stocks to buy [1] - Fidelity Investments and Broadcom reached a legal agreement regarding essential software access, resolving a dispute that arose after Broadcom's acquisition of VMware in 2023 [2] - Citi maintains a Buy rating on Broadcom with a price target of $480, citing increasing AI sales as a key factor, despite the stock being down 4.86% year-to-date as of January 29, 2026 [3] Group 2 - The company is recognized as one of the leading semiconductor businesses globally and has expanded into infrastructure software [3] - There are opinions suggesting that while Broadcom has potential, certain AI stocks may offer greater upside potential with less downside risk [4]

Core Insights - Jacobs Solutions, Inc. is set to report its first-quarter fiscal 2026 results on February 3, with expectations of continued growth in earnings and revenues [1][4] Financial Performance - In the last reported quarter, Jacobs' adjusted earnings and revenues exceeded the Zacks Consensus Estimate by 4.8% and 0.6%, respectively, with year-over-year increases of 27.7% in earnings and 6.6% in revenues [1][2] - The Zacks Consensus Estimate for the upcoming quarter's earnings per share is $1.52, reflecting a 14.3% year-over-year increase from $1.33, while revenues are estimated at $3.18 billion, an 8.5% increase from $2.93 billion in the prior year [3] Growth Drivers - Jacobs' fiscal first-quarter performance is expected to show steady year-over-year growth, driven by strong demand in sectors such as water, life sciences, data centers, transportation, and energy-related infrastructure [4][9] - The Infrastructure & Advanced Facilities segment, which accounted for 89.5% of total revenues in fiscal 2025, is anticipated to benefit from ongoing strength in Water & Environmental, Life Sciences, Advanced Manufacturing, and Critical Infrastructure [6][10] - The PA Consulting segment, making up 10.5% of total revenues, is expected to contribute steadily, supported by public-sector and private-sector advisory work [9] Market Conditions - The company anticipates net revenue growth of 5.5% to 7.5% and a low to mid-15% margin, indicating typical seasonal patterns for the fiscal first quarter [5] - Demand for Critical Infrastructure is expected to remain broad-based, driven by transportation programs and energy-related investments, which continue to support revenue visibility [8] Operational Efficiency - Jacobs' bottom line is likely to have improved year-over-year due to a favorable mix, increased use of global delivery centers, and evolving commercial models that enhance profitability [11]

Core Insights - Digital Realty Trust (DLR) is expected to report fourth-quarter 2025 results on February 5, with anticipated year-over-year growth in revenues and funds from operations (FFO) per share [1][10] Financial Performance - In the prior quarter, DLR reported a core FFO per share of $1.89, exceeding the Zacks Consensus Estimate of $1.78, reflecting strong leasing momentum and improved rental rates [2] - Over the last four quarters, DLR's core FFO per share has consistently surpassed the Zacks Consensus Estimate, with an average beat of 4.43% [2] Growth Drivers - DLR is positioned to benefit from its extensive global data center footprint, driven by digital transformation, cloud computing, and the rise of artificial intelligence [3] - The increasing demand for data centers is leading to heightened leasing activity, contributing to revenue growth for the upcoming quarter [3] - Strategic investments in land, infrastructure, and acquisitions are expected to support DLR's growth trajectory [4] Revenue Projections - The Zacks Consensus Estimate for rental revenues in Q4 is $1.06 billion, representing a 10.8% increase from $958.9 million in the same quarter last year [6] - Interconnection and other revenues are projected at $121.1 million, indicating a 7.8% increase year-over-year [6] - Total revenues for the quarter are estimated at $1.58 billion, suggesting a year-over-year increase of 9.97% [6] Analyst Sentiment - Analysts have shown confidence in DLR's performance, with the Zacks Consensus Estimate for quarterly FFO per share revised upward to $1.83, reflecting a year-over-year growth of 5.78% [7]

Core Viewpoint - Barrick Mining Corporation is expected to report fourth-quarter 2025 results on February 5, with earnings anticipated to rise by 89.1% year-over-year, driven by higher gold prices despite production and cost challenges [1][6]. Group 1: Earnings Expectations - The Zacks Consensus Estimate for Barrick's fourth-quarter earnings is set at 87 cents per share, reflecting an increase from previous estimates over the last 60 days [1]. - Barrick has beaten the Zacks Consensus Estimate for earnings in three of the last four quarters, with an average earnings surprise of approximately 8.7% [2]. Group 2: Production and Costs - Higher gold prices are expected to support Barrick's performance, with gold prices closing nearly 13% higher in the fourth quarter and surging about 65% in 2025 [7]. - However, Barrick is facing weaker year-over-year production, with a projected 18% decline in gold production for the fourth quarter, estimated at around 889,000 ounces [9]. - The company experienced a 12% year-over-year decline in third-quarter gold production, primarily due to the suspension of operations at the Loulo-Gounkoto mine [8]. - Higher production costs are anticipated to impact fourth-quarter results, with cash costs per ounce of gold and all-in-sustaining costs (AISC) increasing by approximately 3% and 2% year-over-year, respectively [10][11]. Group 3: Market Performance and Valuation - Barrick's stock has increased by 176.5% over the past year, outperforming the Zacks Mining – Gold industry's increase of 127.3% and the S&P 500's rise of 18.1% [12]. - The company is currently trading at a forward 12-month earnings multiple of 13.56, which is about a 6% discount compared to the industry average of 14.43 [15]. Group 4: Strategic Positioning - Barrick is well-positioned to benefit from key growth projects that are on schedule and within budget, which should significantly contribute to future production [18]. - The company maintains a robust liquidity position and generates healthy cash flows, allowing it to pursue development, exploration, and acquisition opportunities [19]. - Despite challenges from higher costs and operational issues leading to lower production, Barrick's strong pipeline of growth projects and favorable gold market conditions support a positive outlook [21].

Core Insights - U.S. natural gas prices experienced a significant rally in late January due to extreme cold, supply disruptions, and changes in trader sentiment, despite inventories being above the five-year average [1][2][3] Market Dynamics - Natural gas prices surged, with the March Henry Hub contract finishing around mid-$4 per million British thermal units, marking a recovery from three-month lows earlier in January [2] - The market reacted to colder weather forecasts and supply losses, with daily gains exceeding 10% at one point [2] Weather Impact - Weather forecasts predicting sub-normal temperatures in early February across key regions shifted market sentiment, highlighting the sensitivity of natural gas demand to temperature changes [3] - Even small changes in temperature expectations can significantly impact heating and power generation demand [3] Storage and Supply - Working gas in storage fell by 242 billion cubic feet for the week ended Jan. 23, exceeding market expectations and indicating a faster-than-normal draw compared to the five-year average [4] - Despite inventories being 143 billion cubic feet above the five-year norm, the pace of withdrawals raised concerns about potential late-winter supply tightness [4] Production Disruptions - Freeze-offs in late January temporarily reduced production across key regions, impacting deliverability despite overall high output levels [5] - Temporary disruptions can have immediate pricing effects when demand surges, overshadowing broader production trends [5] Investment Opportunities - Companies such as The Williams Companies (WMB), Expand Energy (EXE), and Comstock Resources (CRK) are positioned to benefit from tighter supply and increased demand during winter market volatility [1][7] - WMB is expected to grow significantly due to its extensive network and large-scale projects, with a projected EPS growth rate of 18.6% over three to five years [9][10] - EXE, as the largest natural gas producer in the U.S., is well-positioned to capitalize on rising demand driven by LNG exports and electrification trends, with a projected EPS growth of 29.5% [11][12] - CRK focuses on the Haynesville and Bossier shales, with a 100% natural gas production profile, and is expected to see a 25% year-over-year EPS surge [13][14]

Core Viewpoint - Bristol-Myers Squibb Company (BMY) is set to report its fourth-quarter and full-year 2025 results on February 5, 2026, with consensus estimates for sales at $12.25 billion and earnings per share (EPS) at $1.15. Recent earnings estimates for 2025 have decreased, while those for 2026 have increased slightly [1][4]. Estimate Movement - The current EPS estimates for Q1, Q2, FY 2025, and FY 2026 are $1.15, $1.51, $6.09, and $6.08 respectively, showing a downward trend from previous estimates [2]. - The earnings surprise history indicates that BMY has consistently beaten estimates in the last four quarters, with an average surprise of 20.05% [2][3]. Factors Influencing Q4 Results - BMY's revenue growth is likely supported by its growth portfolio, which includes drugs like Opdivo, Reblozyl, and Breyanzi, despite facing pressure from declining sales of legacy drugs due to generic competition [4][6]. - Opdivo's sales are projected at $2.6 billion, benefiting from label expansions in new indications [7][8]. - Other drugs such as Orencia and Yervoy are also expected to contribute significantly to sales, with estimates of $989 million and $727 million respectively [9]. Legacy Drug Impact - Legacy products accounted for 47% of total sales in the first nine months of 2025, and their decline has negatively impacted overall revenue growth [21]. - Sales from legacy drugs like Eliquis, Revlimid, and Pomalyst are under pressure from generic competition, although Eliquis continues to show strong demand [14][15]. Strategic Collaborations and Acquisitions - BMY's recent acquisition of Orbital Therapeutics adds a promising preclinical RNA immunotherapy candidate to its pipeline, enhancing its capabilities in autoimmune diseases [23]. - The collaboration with BioNTech for the co-development of pumitamig has shown positive interim results, indicating potential in treating various solid tumors [24][25]. Stock Performance and Valuation - BMY's shares have underperformed compared to the industry and the S&P 500, with a current price/earnings ratio of 9.09x, lower than the industry average [17][19]. - The company is viewed as a safe haven for investors in the biotech sector, with a dividend yield of 4.58% providing an incentive to hold shares [26][27].

Core Insights - Camden Property Trust (CPT) is expected to report fourth-quarter 2025 results on February 5, with anticipated revenue growth year-over-year, although funds from operations (FFO) per share may remain flat [1][8]. Industry Overview - The U.S. apartment market experienced a softening in fundamentals during Q4 2025, with net move-outs of approximately 40,400 units, marking the first seasonal pullback in three years [3]. - Full-year absorption reached just over 365,900 units, indicating a shift back to long-term leasing trends rather than a demand collapse [3]. - Supply pressures remain significant, with around 409,500 units delivered in 2025, including about 89,400 in Q4, leading to increased competition [4]. - Occupancy rates fell to 94.8%, and effective asking rents decreased by 1.7% quarter-over-quarter, with a year-over-year decline of 0.6% in 2025 [4]. Company Performance - In the last reported quarter, Camden Property Trust achieved an FFO per share of $1.70, exceeding the Zacks Consensus Estimate by 0.59%, driven by higher same-property revenues and effective blended lease rates, despite increased interest expenses [2]. - For Q4 2025, the Zacks Consensus Estimate for CPT's revenues is $394.9 million, reflecting a growth of 2.2% from the previous year [7]. - Camden's core FFO per share estimate remains at $1.73, unchanged from the prior year, with expectations for Q4 ranging between $1.71 and $1.75 [9][8]. Market Dynamics - The apartment market's performance is uneven, with supply-heavy regions like Austin, Phoenix, and Denver facing the most significant rent pressures, while coastal and tech-oriented areas like New York and San Francisco continue to see rent growth due to tighter supply [5]. - Camden is expected to benefit from its presence in high-growth markets and a strong resident base, which may help maintain steady rental revenues [6]. - However, the elevated supply of rental units in certain markets is likely to increase competition, hindering rent growth and negatively impacting bottom-line performance [7].

Core Insights - Tyson Foods reported quarterly earnings of $0.97 per share, missing the Zacks Consensus Estimate of $1.01 per share, and down from $1.14 per share a year ago, representing an earnings surprise of -3.96% [1] - The company posted revenues of $14.31 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 1.36%, and up from $13.62 billion year-over-year [2] - Tyson shares have increased by approximately 11.5% since the beginning of the year, outperforming the S&P 500's gain of 1.4% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $1.02 on revenues of $13.75 billion, and for the current fiscal year, it is $3.94 on revenues of $55.74 billion [7] - The estimate revisions trend for Tyson was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Food - Meat Products industry, to which Tyson belongs, is currently ranked in the bottom 26% of over 250 Zacks industries, suggesting potential challenges for stock performance [8] - Beyond Meat, another company in the same industry, is expected to report a quarterly loss of $0.12 per share, with a year-over-year change of +81.5%, and revenues expected to decline by 19.2% from the previous year [9]

ASML Holding N.V. (NASDAQ:ASML) is among the Ken Fisher Stock Portfolio: 12 Best Stocks to Buy. ASML Holding N.V. (ASML) Investors Press Executives on the Outlook Despite the Bookings Success ASML Holding N.V. (NASDAQ:ASML) announced record fourth-quarter bookings of €13.2 billion, significantly above the average analyst expectation of €6.85 billion, as reported by Bloomberg on January 28, 2026. This was due to the demand for innovative chipmaking equipment utilized in AI infrastructure. Extreme ultravio ...

President Donald Trump's nomination of Kevin Warsh to succeed Jerome Powell as Chair of the Federal Reserve is already rippling through markets. 1. Inflation Is ‘A Choice,’ Not a Trade-OffWarsh rejects one of the Fed's most entrenched ideas: that low unemployment mechanically leads to inflation.On Monday, veteran strategist Ed Yardeni wrote that Warsh views inflation as "a byproduct of unsound policy decisions," not the inevitable result of economic strength. Warsh explicitly rejects the Phillips Curve fram ...